Skip to main content
    K

    Kimball Electronics (KE)

    Official site

    INDUSTRIALS • ELECTRICAL EQUIPMENT & PARTS • NASDAQ

    $18.86
    -0.88 (-4.46%)

    Market Cap: $473.60M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Kimball Electronics (KE) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Kimball Electronics (KE) is expected to report earnings on Feb 2, 2027. In the quarter ended Sep 30, 2026, Kimball Electronics reported EPS of $0.20, below the $0.33 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    50%(15/30)
    Avg Surprise
    +11.72%

    Upcoming Estimates

    Reports Feb 2, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.35
    Range$0.31 - $0.37
    4 analysts
    EPS Revisions
    3
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.41-14.6%
    60d ago$0.39-11.2%
    30d ago$0.39-9.7%
    7d ago$0.40-12.5%
    Current$0.35
    Revenue Consensus
    $379.80M
    Range$370.70M - $390.00M
    4 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.39
    Range$0.37 - $0.40
    4 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.43-9.9%
    60d ago$0.41-5.0%
    30d ago$0.40-1.9%
    7d ago$0.39-1.5%
    Current$0.39
    Revenue Consensus
    $386.30M
    Range$383.30M - $392.10M
    4 analysts

    Next Report

    KE has an expected report date of Feb 2, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 25.0% above the $0.28 reported for the quarter ended Dec 31, 2025.

    KE Earnings Call

    The latest KE earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 30 quarters below that had an estimate, KE beat 15, missed 13 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $390.80M, up 6.9% from $365.60M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.20$0.33N/A-39.39%Miss-59.2%33 up, 0 downNov 4, 2026$390.80M
    Jun 30, 2026-$0.08$0.34$0.34 - $0.52-123.53%Miss-123.5%53 up, 1 downAug 12, 2026$371.57M
    Mar 31, 2026$0.33$0.34$0.26 - $0.46-2.94%Miss+22.2%43 up, 1 downMay 5, 2026$352.92M
    Dec 31, 2025$0.28$0.26$0.22 - $0.29+7.69%Beat-3.4%41 up, 1 downFeb 4, 2026$341.28M
    Sep 30, 2025$0.49$0.24N/A+104.17%Beat+122.7%44 up, 0 downNov 5, 2025$365.60M
    Jun 30, 2025$0.34$0.19N/A+78.95%Beat+3.0%40 up, 2 downAug 13, 2025$380.47M
    Mar 31, 2025$0.27$0.19$0.16 - $0.26+42.11%Beat-20.6%40 up, 1 downMay 6, 2025$374.61M
    Dec 31, 2024$0.29$0.23$0.16 - $0.30+26.09%Beat-12.1%4N/AFeb 4, 2025$357.39M
    Sep 30, 2024$0.22$0.25$0.22 - $0.32-12.00%Miss-48.8%41 up, 0 downNov 4, 2024$374.26M
    Jun 30, 2024$0.33$0.44$0.40 - $0.50-25.00%Miss-56.6%50 up, 0 downAug 13, 2024$430.16M
    Mar 31, 2024$0.34$0.40$0.36 - $0.45-15.00%Miss-47.7%50 up, 0 downMay 7, 2024$425.04M
    Dec 31, 2023$0.33$0.40$0.37 - $0.60-17.50%Miss-25.0%60 up, 0 downFeb 5, 2024$421.24M
    Sep 30, 2023$0.43$0.43$0.36 - $0.530.00%In line+13.2%50 up, 0 downNov 6, 2023$438.08M
    Jun 30, 2023$0.76$0.69$0.64 - $0.73+10.14%Beat+90.0%40 up, 0 downAug 16, 2023$496.14M
    Mar 31, 2023$0.65$0.65$0.65 - $0.740.00%In line+20.4%30 up, 0 downMay 4, 2023$484.70M
    Dec 31, 2022$0.44$0.47$0.40 - $0.61-6.38%Miss+120.0%30 up, 0 downFeb 6, 2023$436.70M
    Sep 30, 2022$0.38$0.41$0.39 - $0.58-7.32%Miss+533.3%30 up, 1 downNov 7, 2022$405.89M
    Jun 30, 2022$0.40$0.56$0.51 - $0.62-28.57%Miss-31.0%30 up, 0 downAug 4, 2022$373.50M
    Mar 31, 2022$0.54$0.48$0.48 - $0.48+12.50%Beat+31.7%10 up, 0 downMay 5, 2022$368.06M
    Dec 31, 2021$0.20$0.40$0.40 - $0.40-50.00%Miss-66.7%10 up, 0 downFeb 7, 2022$315.26M
    Sep 30, 2021$0.06$0.33$0.33 - $0.33-81.82%Miss-90.8%1N/ANov 3, 2021$292.72M
    Jun 30, 2021$0.58$0.43$0.43 - $0.43+34.88%Beat+70.6%1N/AAug 4, 2021$329.13M
    Mar 31, 2021$0.41$0.43$0.43 - $0.43-4.65%Miss+64.0%1N/AMay 5, 2021$310.33M
    Dec 31, 2020$0.60$0.34$0.34 - $0.34+76.47%Beat+130.8%1N/AFeb 3, 2021$320.60M
    Sep 30, 2020$0.65$0.33$0.33 - $0.33+96.97%Beat+150.0%1N/ANov 3, 2020$331.75M
    Jun 30, 2020$0.34$0.20$0.20 - $0.20+70.00%Beat+17.2%1N/AAug 18, 2020$286.16M
    Mar 31, 2020$0.25$0.18$0.18 - $0.18+38.89%Beat-45.7%1N/AMay 4, 2020$293.93M
    Dec 31, 2019$0.26N/AN/AN/AN/A0.0%N/AN/AFeb 5, 2020$307.08M
    Sep 30, 2019$0.26N/AN/AN/AN/A+36.8%N/AN/ANov 5, 2019$313.38M
    Jun 30, 2019$0.29N/AN/AN/AN/A+7.4%N/AN/AJul 31, 2019$318.67M
    Mar 31, 2019$0.46N/AN/AN/AN/A+15.0%N/AN/AMay 7, 2019$313.45M
    Dec 31, 2018$0.26N/AN/AN/AN/A-16.0%N/AN/AFeb 6, 2019$284.10M
    Sep 30, 2018$0.19N/AN/AN/AN/A-38.7%N/AN/ANov 6, 2018$265.62M
    Jun 30, 2018$0.27N/AN/AN/AN/A-10.0%N/AN/AAug 1, 2018$276.77M
    Mar 31, 2018$0.40N/AN/AN/AN/A+42.9%N/AN/AMay 2, 2018$283.94M
    Dec 31, 2017$0.31$0.20N/A+54.75%Beat+10.5%N/AN/AFeb 7, 2018$258.15M
    Sep 30, 2017$0.31$0.18N/A+72.22%Beat+29.2%N/AN/ANov 1, 2017$253.20M
    Jun 30, 2017$0.30N/AN/AN/AN/A+50.0%N/AN/AAug 2, 2017$696.80M
    Mar 31, 2017$0.28N/AN/AN/AN/A+7.7%N/AN/AMay 1, 2017$232.93M
    Dec 31, 2016$0.28$0.20N/A+40.00%Beat+75.0%N/AN/AFeb 1, 2017$490000
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Jun 30, 2026 was $1.02, down 8.9% from the year before. It was $1.10 for the year ended Jun 30, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Jun 30, 2026$1.02-8.9%
    Jun 30, 2025$1.12-21.7%
    Jun 30, 2024$1.43-35.9%
    Jun 30, 2023$2.23+85.8%
    Jun 30, 2022$1.20-46.4%
    Jun 30, 2021$2.24+101.8%
    Jun 30, 2020$1.11-7.5%
    Jun 30, 2019$1.20-6.9%
    Jun 30, 2018$1.29+17.2%
    Jun 30, 2017$1.10N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,300 words across 8 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20264,3438
    2026Q2Jun 30, 20264,0418
    2026Q1Mar 31, 20264,4688
    2025Q4Dec 31, 20254,3698
    2025Q3Sep 30, 20255,56810
    2025Q2Jun 30, 20255,89710
    2025Q1Mar 31, 20254,0437
    2024Q4Dec 31, 20245,3539

    2026Q3 Earnings Call

    Opening remarks

    Andrew Regrut Vice President, Investor Relations, Strategic Development and Treasurer Thank you, and good morning, everyone. Welcome to our third quarter conference call. With me here today is Ric Phillips, our Chief Executive Officer; and Jana Croom, Chief Financial Officer. We issued a press release yesterday afternoon with our results for the third quarter of fiscal 2026 ended March 31, 2026. To accompany today's call, a presentation has been posted to the Investor Relations page on our company website. Before we get started, I'd like to remind you that we will be making forward-looking statements that involve risks and uncertainty and are subject to safe harbor provisions as stated in our press release and SEC filings, and that actual results can differ materially from the forward-looking statements. Our commentary today will be focused on adjusted non-GAAP results. Reconciliations of GAAP to non-GAAP amounts are available in our press release. This morning, Ric will start the call with a few opening comments, Jana will review the financial results for the quarter and guidance for fiscal 2026, and Ric will complete our prepared remarks before taking your questions. I'll now turn the call over to Ric.

    Richard Phillips Chief Executive Officer Thank you, Andy, and good morning, everyone. Results for the third quarter were in line with expectations. Sales increased sequentially compared to Q2 driven by strong growth in our Medical vertical market. Margins remain solid and cash from operations was positive for the ninth consecutive quarter. We expect Q4 to be a good finish to the year and we are affirming our guidance for fiscal 2026 with adjusted operating margin estimated to be at the high end of the range. As we look forward, the Medical CMO continues to be a key part of our strategy, and we are making deliberate investments in our capabilities, operating capacity and commercial focus. When volumes ramp, we expect it to become a meaningful driver of both top line growth and margin expansion. In addition, we continue to focus on inorganic growth as a possible complement to this strategy. We believe this could be a powerful combination for the future of our company. Turning to the third quarter. Net sales were $353 million, an increase of 3.4% compared to the prior quarter, with Medical up 10%. At face value, this result was a 6% decline compared to Q3 last year and all 3 end market verticals were down. It's important to highlight, however, that the third quarter of fiscal 2025 included a nonrecurring sale of consigned inventory, totaling $24 million in the medical market. If we normalize the comparison for that event, total company sales this quarter increased nearly 1% year-over-year, with Medical up a robust 17%.

    Frequently Asked Questions About KE

    When is Kimball Electronics's next earnings date?

    Kimball Electronics's next earnings report is expected for Feb 2, 2027.

    Did KE beat earnings estimates last quarter?

    No. Kimball Electronics reported EPS of $0.20 for the quarter ended Sep 30, 2026, below the $0.33 estimate by 39.39%.

    What EPS do analysts expect from KE next quarter?

    The consensus EPS estimate for Kimball Electronics for the quarter ending Dec 31, 2026 is $0.35 from 4 analysts, with estimates from $0.31 to $0.37.

    How often does KE beat earnings estimates?

    Kimball Electronics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +11.64%.